We are live on ! Find out more
HIM

HGC Investment Management Portfolio holdings

AUM $451M
1-Year Est. Return 8.76%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+8.76%
3 Year Est. Return
+34.17%
5 Year Est. Return
+41.5%
10 Year Est. Return
–
AUM
$472M
AUM Growth
+$61.2M
Cap. Flow
+$59.5M
Cap. Flow %
12.61%
Top 10 Hldgs %
26.73%
Holding
185
New
61
Increased
4
Reduced
20
Closed
23

Top Buys

Rank Stock Value
1
DMII
Drugs Made In America Acquisition II Corp
DMII
+$12.2M
2
SBXE.U
SilverBox Corp V Units
SBXE.U
+$9.07M
3
PAII
Pyrophyte Acquisition Corp II
PAII
+$8.55M
4
ITHAU
ITHAX Acquisition Corp III Units
ITHAU
+$7.97M
5
LPCVU
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
+$7.49M

Top Sells

Rank Stock Value
1
DMIIU
Drugs Made In America Acquisition II Corp Unit
DMIIU
+$11.9M
2
PAII.U
Pyrophyte Acquisition Corp II Units
PAII.U
+$8.61M
3
CGCTU
Cartesian Growth Corp III Unit
CGCTU
+$8.14M
4
VRNA
Verona Pharma
VRNA
+$7.88M
5
AEXA
American Exceptionalism Acquisition Corp
AEXA
+$7.75M

Sector Composition

Rank Sector Weight
1 Financials 37.95%
2 Technology 2.96%
3 Healthcare 1.72%
4 Communication Services 1.64%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAII.U
176
Pyrophyte Acquisition Corp II Units
PAII.U
– –
-850,000
Closed -$8.61M
HCMAU
177
HCM III Acquisition Corp Units
HCMAU
$231M
– –
-100,000
Closed -$1.03M
QUMSU
178
Quantumsphere Acquisition Corp Units
QUMSU
$118M
– –
-300,000
Closed -$3.04M
SSEAU
179
Starry Sea Acquisition Corp Unit
SSEAU
– –
-299,986
Closed -$3.04M
GSRFU
180
GSR IV Acquisition Corp Units
GSRFU
– –
-525,000
Closed -$5.32M
DMIIU
181
Drugs Made In America Acquisition II Corp Unit
DMIIU
$520M
– –
-1,200,000
Closed -$11.9M
4 5 6 7
8

Similar funds

CU
CDAM (UK) London, United Kingdom $451M AUM 6.84% 1-Year Est. Return
LVIA
Lind Value II ApS Aarhus C, Denmark $451M AUM 17.35% 1-Year Est. Return
SIM
SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return
MC
Magnitude Capital New York $450M AUM 43.9% 1-Year Est. Return
CFG
Compton Financial Group Towson, Maryland $453M AUM 12.19% 1-Year Est. Return
POEH
Post Oak Energy Holdings Houston, Texas $449M AUM 53.94% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $454M AUM
AIS
American Investment Services Great Barrington, Massachusetts $448M AUM 21.7% 1-Year Est. Return

HGC Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, HGC Investment Management held 185 positions worth $472M, up 15% from $411M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

HGC Investment Management deployed $59.5M of net new capital in Q4 2025, opening 61 new positions and adding to 4 existing holdings. Its largest new stake was Drugs Made In America Acquisition II Corp: 1,230,980 shares worth $12.2M.

By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 43% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was American Exceptionalism Acquisition Corp, an estimated $7.75M trimmed.

  • HGC Investment Management's largest Q4 2025 buy was Drugs Made In America Acquisition II Corp: 1,230,980 shares worth $12.2M.
  • HGC Investment Management added most to CyberArk in Q4 2025, an estimated $3.79M increase.
  • HGC Investment Management's biggest Q4 2025 reduction was American Exceptionalism Acquisition Corp, cutting an estimated $7.75M.
  • HGC Investment Management fully exited Drugs Made In America Acquisition II Corp Unit in Q4 2025, selling an estimated $11.9M.
  • HGC Investment Management's ten largest holdings make up 27% of its $472M portfolio in Q4 2025.
  • HGC Investment Management opened 61 new positions and closed 23 in Q4 2025.
  • HGC Investment Management's portfolio value rose 15% quarter-over-quarter to $472M.

Based on HGC Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.